Literature DB >> 27335160

Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.

Ping Li1, Qing Gu2, Xuechang Wu3.   

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent. The aim of this study is to produce large quantities of highly pure and bioactive recombinant human TRAIL. Here, TRAIL was expressed in soluble form by pH-stat fed-batch cultivation and purified using a rapid and simple two-step chromatographic procedure. To improve the soluble yield, expression of TRAIL in Escherichia coli was induced with low IPTG concentration (0.1 mM) at low temperature (28 °C) supplemented with ZnSO4 (0.5 mM), using glycerol as carbon source. Under the optimized conditions, 4.14 ± 0.19 g/L of TRAIL in soluble form was achieved at 19 h without pure oxygen. To purify the recombinant TRAIL, we developed an efficient two-step chromatographic procedure including affinity chromatography and cation-exchange chromatography, especially improved the cation-exchange chromatography using a combination of pH and NaCl gradients strategy. Consequently, 4313.5 mg of target protein with high purity (98.1%) was obtained from 2.3 L of cell broth. Our results also showed that the purified TRAIL was with ordered secondary and tertiary structures, in homogeneous form and with strong cytotoxicity.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Anticancer activity; Fed-batch cultivation; Purification; Soluble expression; TRAIL

Mesh:

Substances:

Year:  2016        PMID: 27335160     DOI: 10.1016/j.pep.2016.06.007

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  4 in total

1.  A simplified method for the efficient purification and refolding of recombinant human TRAIL.

Authors:  Zhenjiang Zhang; Su Bin Hahn; Thong M Cao; Michael R King
Journal:  Biotechnol Prog       Date:  2020-05-11

2.  Improved production of the recombinant phospholipase A1 from Polybia paulista wasp venom expressed in bacterial cells for use in routine diagnostics.

Authors:  Amilcar Perez-Riverol; Alexis Musacchio-Lasa; Luis Gustavo Romani Fernandes; Jose Roberto Aparecido Dos Santos-Pinto; Franciele Grego Esteves; Murilo Luiz Bazon; Ricardo de Lima Zollner; Mario Sergio Palma; Márcia Regina Brochetto-Braga
Journal:  3 Biotech       Date:  2020-04-27       Impact factor: 2.406

3.  Application of an Autoinduction Strategy to Optimize the Heterologous Production of an Antitumor Bispecific Fusion Protein Based on the TRAIL Receptor-Selective Mutant Variant in Escherichia coli.

Authors:  Alina Isakova; Artem Artykov; Yekaterina Vorontsova; Dmitry Dolgikh; Mikhail Kirpichnikov; Marine Gasparian; Anne Yagolovich
Journal:  Mol Biotechnol       Date:  2022-09-12       Impact factor: 2.860

4.  GroEL/ES mediated the in vivo recovery of TRAIL inclusion bodies in Escherichia coli.

Authors:  Zhanqing Wang; Min Zhang; Xin Lv; Jiying Fan; Jian Zhang; Jing Sun; Yaling Shen
Journal:  Sci Rep       Date:  2018-10-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.